XETRA:EUZ

Eckert & Ziegler SE · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 12:50 UTC

Last close

n/aEUR

Market data

  • 17.7xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
  • 30.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 15.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 11.0%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.18Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

Five bars, one line

lens 7 of 9
1.52x
1.91x
1.52x
1.56x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.52x

    Its own average over 10 years, 205.7M.

  • Profit1.91x

    Its own average over 10 years, 25.6M.

  • Free cash flow1.52x

    Its own average over 10 years, 22.6M.

  • Debt1.56x

    Its own average over 10 years, 28.7M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 1.91 times.

Sales is 1.52 times its own 10-year average; Profit is 1.91 times its own 10-year average; Free cash flow is 1.52 times its own 10-year average; Debt is 1.56 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average1.52
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Profit against its own 10-year average1.91
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Free cash flow against its own 10-year average1.52
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Debt against its own 10-year average1.56
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    EUR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.